14 pending office actions • 13 art units • 13 examiners • 0 of 14 (0%) have an AI response strategy ready • 24 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 14 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 14 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 9 (64%) |
| §102 only | 2 (14%) |
| No statute on record | 3 (21%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MINCHELLA, KAITLYN L | 2 | 27.1% | +21.7% |
| DROUIN, STEVE HOANG | 1 | — | — |
| AMIN, ALPA NILESH | 1 | 50.0% | +0.0% |
| ELENISTE, PIERRE PAUL | 1 | 38.5% | +30.2% |
| NOTTINGHAM, KYLE GREGORY | 1 | 60.8% | +33.8% |
| STIGELL, THEODORE J | 1 | 78.2% | +14.7% |
| VANHORN, ABIGAIL LOUISE | 1 | 46.7% | +22.1% |
| MCKNIGHT, CIARA A | 1 | 61.8% | +34.7% |
| PURDY, KYLE A | 1 | 40.8% | +36.8% |
| OYEYEMI, OLAYINKA A | 1 | 60.5% | +46.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 15028253 | METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES | MINCHELLA, KAITLYN L | 14d |
| 15489658 | METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES | MINCHELLA, KAITLYN L | 21d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17970448 | Magnetic-Responsive Photosensitizer Nanoplatform and Uses Thereof | NOTTINGHAM, KYLE GREGORY | 92d overdue |
| 17677600 | Combinatorial Microarray Assay for Detecting and Genotyping SARS-CoV-2 | OYEYEMI, OLAYINKA A | 78d overdue |
| 17797970 | EXTENDABLE NEEDLE | STIGELL, THEODORE J | 46d overdue |
| 17787780 | HISTIDINE-LYSINE POLYMERS AND METHODS FOR DELIVERING MRNA USING THE SAME | VANHORN, ABIGAIL LOUISE | 31d overdue |
| 15028253 | METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES | MINCHELLA, KAITLYN L | 14d |
| 17774215 | METHODS FOR DISTINGUISHING THE STAGES OF BACTERIAL VAGINOSIS | MCKNIGHT, CIARA A | 19d |
| 15489658 | METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES | MINCHELLA, KAITLYN L | 21d |
| 17767783 | COMPOSITIONS AND METHODS FOR DELIVERING NUCLEIC ACIDS TO CELLS | PURDY, KYLE A | 27d |
| Art Unit | Apps |
|---|---|
| 1685 | 2 |
| 1627 | 1 |
| 1655 | 1 |
| 1622 | 1 |
| 1621 | 1 |
| 3783 | 1 |
| 1636 | 1 |
| 1656 | 1 |
| 1611 | 1 |
| 1681 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18354910 | Uses of Dihydroorotate Dehydrogenase Inhibitors | DROUIN, STEVE HOANG | 1627 | §103 | Non-Final OA | 42d overdue | Pending | Jul 19, 2023 |
| 18261203 | METHODS AND PLATFORMS FOR PROMOTING ANTIGEN-SPECIFIC TOLERANCE IN THE TREATMENT OF TYPE 1 DIABETES AND GRAFT REJECTION AND COMPOSITIONS RELATING THERETO | AMIN, ALPA NILESH | 1655 | §102 | Non-Final OA | 40d | Pending | Jul 12, 2023 |
| 18173962 | THERAPEUTIC TARGETING OF GPR68 TO INDUCE FERROPTOSIS | ELENISTE, PIERRE PAUL | 1622 | Other | Non-Final OA | 36d | Pending | Feb 24, 2023 |
| 17970448 | Magnetic-Responsive Photosensitizer Nanoplatform and Uses Thereof | NOTTINGHAM, KYLE GREGORY | 1621 | §103 | Non-Final OA | 92d overdue | Pending | Oct 20, 2022 |
| 17797970 | EXTENDABLE NEEDLE | STIGELL, THEODORE J | 3783 | §102 | Non-Final OA | 46d overdue | Pending | Aug 05, 2022 |
| 17787780 | HISTIDINE-LYSINE POLYMERS AND METHODS FOR DELIVERING MRNA USING THE SAME | VANHORN, ABIGAIL LOUISE | 1636 | §103 | Non-Final OA | 31d overdue | Pending | Jun 21, 2022 |
| 17774215 | METHODS FOR DISTINGUISHING THE STAGES OF BACTERIAL VAGINOSIS | MCKNIGHT, CIARA A | 1656 | §103 | Final Rejection | 19d | Pending | May 04, 2022 |
| 17767783 | COMPOSITIONS AND METHODS FOR DELIVERING NUCLEIC ACIDS TO CELLS | PURDY, KYLE A | 1611 | §103 | Non-Final OA | 27d | Pending | Apr 08, 2022 |
| 17677600 | Combinatorial Microarray Assay for Detecting and Genotyping SARS-CoV-2 | OYEYEMI, OLAYINKA A | 1681 | Other | Non-Final OA | 78d overdue | Pending | Feb 22, 2022 |
| 17616584 | ADJUVANTS FOR IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF | HIBSHMAN, SARAH GRACE | 1693 | §103 | Non-Final OA | 34d | Pending | Dec 03, 2021 |
| 17465113 | TRANS-ESOPHAGEAL AORTIC FLOW RATE CONTROL | LABRANCHE, BROOKE N | 3771 | §103 | Non-Final OA | 70d | Pending | Sep 02, 2021 |
| 16813263 | Methods of Generating Mature Human Muscle Fibers | POPA, ILEANA | 1633 | §103 | Non-Final OA | 89d overdue | Pending | Mar 09, 2020 |
| 15489658 | METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES | MINCHELLA, KAITLYN L | 1685 | §103 | Final Rejection | 21d | Pending | Apr 17, 2017 |
| 15028253 | METHODS FOR DISTINGUISHING INFLAMMATORY BOWEL DISEASES USING MICROBIAL COMMUNITY SIGNATURES | MINCHELLA, KAITLYN L | 1685 | Other | Final Rejection | 14d | Pending | Apr 08, 2016 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial